Trinity Biotech (FRA:TRB0) FFO


FRA:TRB0 Trinity Biotech PLC FRA:TRB0
25 GF Score
Price €2.12
GF Value €4.34
! 7 Warning Signs
View Full Analysis

What is Trinity Biotech FFO?

FFO (Funds from operations) only applies to REITs.

FRA:TRB0
25GF Score
Trinity Biotech PLC FRA:TRB0
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Trinity Biotech (FRA:TRB0) Overvalued in 2026?

Based on GuruFocus' analysis, Trinity Biotech stock appears to be undervalued. The current stock price of €2.12 is trading 51.2% below its estimated GF Value™ of €4.34.

Key valuation signals for FRA:TRB0:

  • FFO:
  • GF Value™: €4.34 vs. price of €2.12 (51.2% below fair value)
  • GF Score™: 25/100 with 7 warning signs

No single metric tells the full story. See the FRA:TRB0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Trinity Biotech Business Description

Other Exchanges TRIB:USA
Address IDA Business Park, Bray, County Wicklow, Dublin, IRL, A98 H5C8
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has three segments, namely the Americas, Asia/Africa, and Europe, from which it derives a majority of its revenue from the Americas segment.
25GF Score

Get the complete analysis for FRA:TRB0

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.12
Price
€4.34
GF Value